News and press releases

EMA qualifies first artificial intelligence tool to diagnose inflammatory liver disease (MASH) in biopsy samples

EMA’s human medicines committee (CHMP) has issued the first Qualification Opinion (QO) on an innovative development methodology based on artificial intelligence (AI). The tool,…

Mar 20, 2025 - 12:08
 0
EMA qualifies first artificial intelligence tool to diagnose inflammatory liver disease (MASH) in biopsy samples
EMA’s human medicines committee (CHMP) has issued the first Qualification Opinion (QO) on an innovative development methodology based on artificial intelligence (AI). The tool,…
Read More

Tags:

Previous Article

Germany approves EUR 500 billion for infrastructure

Next Article

Opinions and letters of support on the qualification of novel methodologies for ...

Related Posts

Joint strategy sets direction of EMA and EU medicines regulatory agencies to 2028

Joint strategy sets direction of EMA and EU medicines r...

Mar 18, 2025  0

Unregulated advanced therapy medicinal products pose serious risks to health

Unregulated advanced therapy medicinal products pose se...

Mar 13, 2025  0

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-15 January 2025

Meeting highlights from the Committee for Veterinary Me...

Feb 9, 2025  0